Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6751 to 6765 of 8314 results

  1. Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years (TA554)

    This guidance has been updated and replaced by NICE technology appraisal guidance 975.  

    Technology appraisal guidance
    Published
    21 December 2018

  2. Interstitial cystitis: oral pentosan polysulfate sodium (ESUOM43)

    This guidance has been updated and replaced by NICE technology appraisal guidance 610.

    Evidence summary
    Published
    21 April 2015

  3. Parkinson's disease with motor fluctuations: safinamide (ES6)

    This evidence summary has been updated and replaced by NICE guideline NG71.

    Evidence summary
    Published
    21 February 2017

  4. Peezy Midstream for urine collection (MIB183)

    NICE has withdrawn the med tech innovation briefing (MIB) on Peezy Midstream for urine collection.

    Medtech innovation briefing
    Published
    8 May 2019

  5. Selpercatinib for treating advanced thyroid cancer with RET alterations (TA742)

    This guidance has been updated and replaced by NICE technology appraisal guidance 1038.

    Technology appraisal guidance
    Published
    3 November 2021

  6. Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal) (TA762)

    This guidance has been updated and replaced by NICE technology appraisal guidance 1040.

    Technology appraisal guidance
    Published
    2 February 2022

  7. Maternal and child nutrition (PH11)

    This guideline has been updated and replaced by NICE guideline NG247.

    Public health guideline
    Last updated
    1 November 2014

  8. Weight management: lifestyle services for overweight or obese children and young people (PH47)

    This guideline has been updated and replaced by NICE guideline NG246.

    Public health guideline
    Published
    23 October 2013

  9. Weight management: lifestyle services for overweight or obese adults (PH53)

    This guideline has been updated and replaced by NICE guideline NG246.

    Public health guideline
    Published
    28 May 2014

  10. Obesity: working with local communities (PH42)

    This guideline has been updated and replaced by NICE guideline NG246.

    Public health guideline
    Last updated
    5 June 2017

  11. Preventing excess weight gain (NG7)

    This guideline has been updated and replaced by NICE guideline NG246.

    NICE guideline
    Published
    13 March 2015

  12. Obesity: identification, assessment and management (CG189)

    This guideline has been updated and replaced by NICE guideline NG246.

    Clinical guideline
    Last updated
    26 July 2023

  13. Obesity prevention (CG43)

    This guideline has been updated and replaced by NICE guideline NG246.

    Clinical guideline
    Last updated
    13 March 2015

  14. Liquid-based cytology for cervical screening (TA5)

    This guidance has been replaced by NICE technology appraisal guidance 69.

    Technology appraisal guidance
    Published
    26 June 2000

  15. Management of aggression, agitation and behavioural disturbances in dementia: valproate preparations (ESUOM41)

    This evidence summary has been updated and replaced by NICE guideline NG97.

    Evidence summary
    Published
    10 March 2015